Phlebotomy Considerations in Tetralogy of Fallot

Patient Evaluation and Risk Assessment

The American Heart Association recommends that patients with tetralogy of Fallot (TOF), particularly those with unrepaired or palliated forms, maintain a delicate hemodynamic balance that is highly sensitive to volume status 1
The degree of cyanosis in TOF is determined by the severity of right ventricular outflow tract (RVOT) obstruction and the resultant right-to-left shunting across the ventricular septal defect 2
Unrepaired or palliated TOF patients are at highest risk and require evaluation at an adult congenital heart disease (ACHD) center regarding suitability for repair 1
Repaired TOF patients with significant residual lesions (pulmonary regurgitation, RV dysfunction, residual RVOT obstruction) require careful hemodynamic assessment 1, 2

RV function and size must be assessed via comprehensive echocardiography or cardiac MRI 1, 2
Severity of pulmonary regurgitation and residual RVOT obstruction should be quantified 2
Presence of arrhythmias (QRS duration >180 ms indicates high risk for ventricular tachycardia) 2, 3
Decreased preload reduces RV filling and cardiac output, potentially worsening cyanosis 3
Hypotension can precipitate right-to-left shunting if residual septal defects exist 3

Pregnancy in unrepaired TOF is contraindicated 2
Even in repaired TOF, volume shifts during pregnancy require careful management, and any phlebotomy must account for the physiologic anemia of pregnancy 2

Do not assume repaired TOF patients are "normal" - residual hemodynamic abnormalities are common and affect tolerance to volume loss 1, 2
Avoid tachycardia which reduces diastolic filling time and coronary perfusion, potentially triggering arrhythmias 3
Never ignore signs of decompensation such as worsening cyanosis, syncope, or palpitations, which mandate immediate evaluation 2

The American College of Cardiology and American Heart Association guidelines do not establish specific hemoglobin transfusion thresholds for patients with tetralogy of Fallot, focusing instead on surgical management, imaging surveillance, and hemodynamic monitoring 4, 5, 6

Repaired tetralogy of Fallot patients often have residual lesions, including pulmonary regurgitation, RV dysfunction, residual RVOT obstruction, and tricuspid regurgitation, which affect their tolerance to volume loss and anemia 5, 6
Patients with significant residual RVOT obstruction may not tolerate anemia well, and those with moderate-to-severe RV dysfunction or enlargement have limited cardiac reserve 6, 7

The American College of Cardiology recommends that transfusion decisions be made in consultation with an adult congenital heart disease specialist, considering the unique pathophysiology of each patient 4, 5
A restrictive transfusion strategy may be used in stable, well-repaired patients with minimal residual lesions, but a lower threshold for transfusion is recommended for patients with significant residual hemodynamic abnormalities, RV dysfunction, or active arrhythmias 6

In patients with repaired or unrepaired Tetralogy of Fallot, a QRS duration > 180 ms is associated with a markedly increased risk of ventricular tachycardia and sudden cardiac death; therefore, a more liberal transfusion threshold (higher hemoglobin target) is recommended to mitigate arrhythmic risk. 8

Exercise intolerance or a decline in functional capacity in Tetralogy of Fallot patients signals insufficient cardiac reserve; transfusion is advised when hemoglobin falls below 9–10 g/dL to ensure adequate oxygen delivery. 8